Equillium Inc (EQ)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Daniel Mark Bradbury
Employees:
11
2223 AVENIDA DE LA PLAYA, SUITE 108, LA JOLLA, CA 92037
(858) 412-5302

Equillium, Inc., a biotechnology company, develops products for autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. Its primary product candidate is EQ001, a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase 1b/2 clinical trials for the treatment of acute graft-versus-host disease; and Phase 1 clinical trial for the treatment of asthma and lupus nephritis. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was founded in 2017 and is headquartered in San Diego, California.

Data derived from most recent annual or quarterly report
Market Cap 167.188 Million Shares Outstanding29.383 Million Avg 30-day Volume 70.7 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 11.33 / 3.47 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million

Are you looking for this stock instead?

View SEC Filings from EQ instead.

View recent insider trading info

Funds Holding EQ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EQ BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

16.1 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

8.1 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CONNELLY STEPHEN CHIEF SCIENTIFIC OFFICER

  • Officer
  • Director
993,000 2021-10-06 4

KEYES JASON A CHIEF FINANCIAL OFFICER

  • Officer
120,431 2021-09-27 8

ZEDELMAYER CHRISTINE SR. VICE PRESIDENT AND COO

  • Officer
90,509 2021-06-10 3

ROTHMAN JOEL CHIEF DEVELOPMENT OFFICER

  • Officer
22,991 2021-06-10 2

MANIAN BALA S

  • Director
20,770 2021-05-26 1

DEMSKI MARTHA J

  • Director
20,770 2021-05-26 1

PRUZANSKI MARK

  • Director
20,770 2021-05-26 1

MCDERMOTT CHARLES DOUGLAS

  • Director
20,770 2021-05-26 1

XU YU (KATHERINE)

  • Director
30,000 2021-03-04 2

DECHENG CAPITAL GLOBAL LIFE SCIENCES FUND IV, L.P.

DECHENG CAPITAL MANAGEMENT IV (CAYMAN), LLC

CUI XIANGMIN

  • 10% Owner
3,285,710 2021-02-05 1

THOMAS DOLCA CHIEF MEDICAL OFFICER

  • Officer
0 2021-01-11 2

BRADBURY DANIEL EXECUTIVE CHAIRMAN

  • Officer
  • Director
  • 10% Owner
0 2021-01-04 1

STEEL BRUCE D. PRESIDENT AND CEO

  • Officer
  • Director
  • 10% Owner
0 2021-01-04 1

POLU KRISHNA R CHIEF MEDICAL OFFICER

  • Officer
0 2020-04-22 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

CONNELLY STEPHEN - Director - Officer CHIEF SCIENTIFIC OFFICER

2021-10-07 21:02:35 -0400 2021-10-06 M 5,625 d 0 direct

CONNELLY STEPHEN - Director - Officer CHIEF SCIENTIFIC OFFICER

2021-10-07 21:02:35 -0400 2021-10-06 S 5,625 $7.01 d 993,000 direct -0.3322 -1.8272 0.0 1 -2.6578 5

CONNELLY STEPHEN - Director - Officer CHIEF SCIENTIFIC OFFICER

2021-10-07 21:02:35 -0400 2021-10-06 S 2,467 $7.01 d 993,000 direct -0.3322 -1.8272 0.0 1 -2.6578 5

CONNELLY STEPHEN - Director - Officer CHIEF SCIENTIFIC OFFICER

2021-10-07 21:02:35 -0400 2021-10-06 M 5,625 $4.75 a 998,625 direct -0.3322 -1.8272 0.0 1 -2.6578 5

CONNELLY STEPHEN - Director - Officer CHIEF SCIENTIFIC OFFICER

2021-10-07 21:02:35 -0400 2021-10-06 M 2,467 d 0 direct

CONNELLY STEPHEN - Director - Officer CHIEF SCIENTIFIC OFFICER

2021-10-07 21:02:35 -0400 2021-10-06 M 2,467 $2.80 a 995,467 direct -0.3322 -1.8272 0.0 1 -2.6578 5

KEYES JASON A - Officer CHIEF FINANCIAL OFFICER by the keyes trust dated september 10, 2004

2021-09-29 13:02:22 -0400 2021-09-27 S 8,000 $6.74 d 102,720 indirect 10.8943 11.0569 13.6585 5 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
EQUILLIUM INC EQ 2021-10-26 22:15:03 UTC -1.9225 1.9925 45000
EQUILLIUM INC EQ 2021-10-26 21:45:03 UTC -1.9225 1.9925 45000
EQUILLIUM INC EQ 2021-10-26 21:15:03 UTC -1.9225 1.9925 45000
EQUILLIUM INC EQ 2021-10-26 20:45:03 UTC -1.9225 1.9925 45000
EQUILLIUM INC EQ 2021-10-26 20:15:03 UTC -1.9225 1.9925 45000
EQUILLIUM INC EQ 2021-10-26 19:45:03 UTC -1.9225 1.9925 45000
EQUILLIUM INC EQ 2021-10-26 19:15:03 UTC -1.9225 1.9925 45000
EQUILLIUM INC EQ 2021-10-26 18:45:03 UTC -1.9225 1.9925 45000
EQUILLIUM INC EQ 2021-10-26 18:15:03 UTC -1.9225 1.9925 45000
EQUILLIUM INC EQ 2021-10-26 17:45:03 UTC -1.9225 1.9925 45000
EQUILLIUM INC EQ 2021-10-26 17:15:03 UTC -1.9225 1.9925 45000
EQUILLIUM INC EQ 2021-10-26 16:45:04 UTC -1.9225 1.9925 45000
EQUILLIUM INC EQ 2021-10-26 16:15:03 UTC -1.9225 1.9925 45000
EQUILLIUM INC EQ 2021-10-26 15:45:03 UTC -1.9225 1.9925 45000
EQUILLIUM INC EQ 2021-10-26 15:15:03 UTC -1.9225 1.9925 45000
EQUILLIUM INC EQ 2021-10-26 14:45:03 UTC -2.3769 2.4469 45000
EQUILLIUM INC EQ 2021-10-26 14:15:05 UTC -2.3769 2.4469 45000
EQUILLIUM INC EQ 2021-10-26 13:45:03 UTC -2.3769 2.4469 45000
EQUILLIUM INC EQ 2021-10-26 13:15:03 UTC -2.3769 2.4469 45000
EQUILLIUM INC EQ 2021-10-26 12:45:03 UTC -2.3769 2.4469 50000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund EQ -3300.0 shares, $-19437.0 2021-06-30 N-PORT

Elevate your investments